⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18903926 | 0.81 | TSHR (0.39) | — | |
| SCHEMBL13059617 | 0.80 | TSHR (0.37) | — | |
| Formaldehyde SCHEMBL3824097 | 0.79 | TSHR (0.46) | — | |
| SCHEMBL8903958 | 0.79 | — | — | |
| SCHEMBL167149 | 0.78 | — | — | |
| SCHEMBL667630 | 0.78 | TSHR (0.50) | — | |
| SCHEMBL10717198 | 0.77 | — | — | |
| Ammonia Solution, Strong SCHEMBL3909004 | 0.76 | TSHR (0.48) | — | |
| SCHEMBL585604 | 0.76 | — | — | |
| SCHEMBL7047649 | 0.76 | HMGCR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024034583-A1 | METHOD FOR PRODUCING HALOGENATED ALKENE COMPOUND | ダイキン工業株式会社 | 2024-02-15 | — | — | WO | disclosed |
| EP-2268140-B1 | NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA INC (US) | 2020-11-11 | — | — | EP | disclosed |
| US-20160137592-A1 | NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA, INC. | 2016-05-19 | — | — | US | disclosed |
| US-9212155-B2 | Compounds advantageous in the treatment of central nervous system diseases and disorders | AURIMMED PHARMA, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-9206143-B2 | Compounds advantageous in the treatment of central nervous system diseases and disorders | AURIMMED PHARMA, INC. (US) | 2015-12-08 | — | — | US | disclosed |
| US-20110046138-A1 | NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA, INC. | 2011-02-24 | — | — | US | disclosed |
| CN-1660766-A | Ramification of omega oxyacid with lateral chain of chirality methyl | SHANGHAI INST ORGANIC CHEM (CN) | 2005-08-31 | — | — | CN | disclosed |